期刊文献+

基质金属蛋白酶-2在胃癌组织中的表达及与腹膜扩散的关系 被引量:1

Expression of matrix metalloproteinase-2 and its relationship with peritoneal dissemination of gastric carcinoma
在线阅读 下载PDF
导出
摘要 目的探讨基质金属蛋白酶-2(matrix metalloprotelnase-2,MMP-2)在胃癌组织中的表达及其与肿瘤浸润、腹膜转移之间的关系。方法应用免疫组化S-P法检测82例胃癌组织中MMP-2的表达水平,并结合临床病理参数进行综合分析。结果 MMP-2在胃癌组织中呈高表达,与癌组织的浸润深度、淋巴结转移、临床病理分期及胃癌腹膜扩散具有相关性(P<0.05)。结论 MMP-2在胃癌的表达反应了肿瘤的生物学行为,MMP-2高表达促进肿瘤转移,对胃癌的预后判定有一定意义。 To investigate the expression of matrix metalloproteinase-2(MMP-2) in tissues of gastric carcinoma and its correlation with the invasion and peritoneal dissemination of gastric carcinoma. Immunohistochemistry was used to examine and analyze the expression of MMP-2 in 82 specimens of gastric carcinoma tissues. MMP-2 showed high expression in gastric carcinoma tissues.The expression of MMP-2 was closely related to the depth of invasion,lymph node metastasis,clinical stage and peritoneal dissemination of gastric carcinoma(P 0.05). The expression of MMP-2 reflects the biological behavior of tumor.The high expression of MMP-2 can promote tumor metastasis,which has certain significance in the prognosis of gastric cancer
出处 《实用医院临床杂志》 2012年第2期63-64,共2页 Practical Journal of Clinical Medicine
关键词 胃癌 基质金属蛋白酶-2 腹膜扩散 Gastric carcinoma Matrix metalloproteinase-2 Peritoneal dissemination
  • 相关文献

参考文献8

二级参考文献36

  • 1肖春花,冯玉梅,李晓青,郝希山.基质金属蛋白酶-2和纤维粘连蛋白在乳腺癌细胞系的定量表达[J].中华实验外科杂志,2005,22(5):527-529. 被引量:7
  • 2Monig SP,Zirbes TK,Schroder W,et al.Staging of gastric cancer:correlation of lymph node size and metastatic infiltration[J].Am J Roentgenol,1999,172(2):365-367.
  • 3Maatta M,Soini Y,Liakka A,et al.Differential expression of matrix metalloproteinase MMP-2,MMP-9,and membrane type 1-MMP in human hepatocellular and pancreatic adenocarcinomas:implication for tumor progression and clinical prognoss[J].Clin Cancer Res,2000,
  • 4Westermarck J,Kahari VM.Regulation of matrix metalloproteinase expression in tumor invasion[J].FASEB J,1999,13(8):781-792.
  • 5Bosari S,Delelli RA,Healtley GL,et al.Microvessel quantitation and progress in invasive breast carcinoma[J].Hum Pathol,1992,23(4):755-763.
  • 6Allgayer H,Babic R,Grutzner KU,et al.Tumor-associated proteases and inhibitors in gastric cancer:analysis of prognostic impact and individual risk protease patterns[J].Clin Exp Metastasis,1998,16(1):62-73.
  • 7Monig SP,Baldus SE,Hennecken JK,et al.Expression of MMP-2 associated with progression and lymph node metastasis of gastric carcinoma.Histopathology,2001,39(4):597-602.
  • 8Folkman J.Angiogenesis research: from laboratory to clinic [J].Forum Genova,1999,9(Suppl 3 ): 59-62.
  • 9Fang J,Shing Y,Wiederschain D,et al.Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model [J].Proc Natl Acad Sci USA,2000,97: 3884-3889.
  • 10Rothenberg ML,Nelson AR,Hande KR.New drugs on the horizon: matrix metalloproteinase inhibitors [J].Stem cells,1999,17: 237-240.

共引文献43

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部